Bayer shareholders on Friday cast a vote of disapproval of the German drugmaker's top management amid anger over a stock price slump as litigation risks mount from the $63 billion takeover of seed maker Monsanto.
from Reuters: Money News https://reut.rs/2DwDNUH
via
IFTTT
0 comments: